For women in menopause, semaglutide remains a trusted option with strong safety data and availability, while tirzepatide may be considered if additional support is needed
This integrative strategy, combining systemic regulation with personalized medicine, provides a safer and more effective treatment option for patients with PCOS
LiXYangXLiYYuanMTianCZhangXet alMitochondria and the pathophysiological mechanism of atrial fibrillation
The refined TED outcome, which focuses on pathognomonic manifestations, followed the same trend, showing a protective effect at all time points, including a one-year risk of 0.42% in the GLP-1 group compared to 0.53% in the control group (HR 0.79)
More studies are needed, but the potential is there